212 related articles for article (PubMed ID: 18415081)
21. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.
Prins NH; Van Haselen JF; Lefebvre RA; Briejer MR; Akkermans LM; Schuurkes JA
Br J Pharmacol; 1999 Jul; 127(6):1431-7. PubMed ID: 10455293
[TBL] [Abstract][Full Text] [Related]
22. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro.
Kim HS; Choi EJ; Park H
Neurogastroenterol Motil; 2008 Feb; 20(2):169-76. PubMed ID: 17931343
[TBL] [Abstract][Full Text] [Related]
23. 5-Hydroxytryptamine4 receptor agonists and colonic motility.
Kim HS
J Smooth Muscle Res; 2009 Feb; 45(1):25-9. PubMed ID: 19377270
[TBL] [Abstract][Full Text] [Related]
24. The novel, potent and highly selective 5-HT
Jeong EJ; Chung SY; Hong HN; Oh SW; Sim JY
Br J Pharmacol; 2018 Feb; 175(3):485-500. PubMed ID: 29139561
[TBL] [Abstract][Full Text] [Related]
25. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
[TBL] [Abstract][Full Text] [Related]
26. Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors.
Jin JG; Foxx-Orenstein AE; Grider JR
J Pharmacol Exp Ther; 1999 Jan; 288(1):93-7. PubMed ID: 9862758
[TBL] [Abstract][Full Text] [Related]
27. A 5-HT4-like receptor in human right atrium.
Kaumann AJ; Sanders L; Brown AM; Murray KJ; Brown MJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):150-9. PubMed ID: 1658664
[TBL] [Abstract][Full Text] [Related]
28. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.
Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Genov D; Goldblum AA; Humphrey PP; Jiang L; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
Bioorg Med Chem Lett; 2012 Oct; 22(19):6048-52. PubMed ID: 22959244
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of a novel 5-HT4 receptor agonist, TS-951, in vitro.
Kajita S; Ito C; Kawamura R; Yasuda S; Isobe Y; Fukushima K
Pharmacology; 2001 Jul; 63(1):8-16. PubMed ID: 11408827
[TBL] [Abstract][Full Text] [Related]
30. Identification of SK-951, a novel benzofuran derivative, as an agonist to 5-HT4 receptors.
Takeda M; Tsukamoto K; Mizutani Y; Suzuki T; Taniyama K
Jpn J Pharmacol; 1999 Feb; 79(2):203-12. PubMed ID: 10202856
[TBL] [Abstract][Full Text] [Related]
31. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the intrinsic defecation reflex by mosapride, a 5-HT4 agonist, in chronically lumbosacral denervated guinea pigs.
Kojima Y; Fujii H; Katsui R; Nakajima Y; Takaki M
J Smooth Muscle Res; 2006 Oct; 42(5):139-47. PubMed ID: 17159330
[TBL] [Abstract][Full Text] [Related]
33. Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon.
McLean PG; Coupar IM
Br J Pharmacol; 1996 Jun; 118(4):1058-64. PubMed ID: 8799582
[TBL] [Abstract][Full Text] [Related]
34. The selective 5-hydroxytryptamine (5-HT)4-receptor agonist RS67506 enhances lower intestinal propulsion in mice.
Nagakura Y; Ito H; Kiso T; Naitoh Y; Miyata K
Jpn J Pharmacol; 1997 Jun; 74(2):209-12. PubMed ID: 9243330
[TBL] [Abstract][Full Text] [Related]
35. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum.
McLean PG; Coupar IM; Molenaar P
Br J Pharmacol; 1995 May; 115(1):47-56. PubMed ID: 7647983
[TBL] [Abstract][Full Text] [Related]
37. Effect of mosapride citrate hydrate on the colon cleansing action of polyethylene glycol electrolyte lavage solution (PEG-ELS) in guinea pigs.
Mine Y; Morikage K; Oku S; Yoshikawa T; Shimizu I; Yoshida N
J Pharmacol Sci; 2009 Aug; 110(4):415-23. PubMed ID: 19602846
[TBL] [Abstract][Full Text] [Related]
38. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
Tack J; Camilleri M; Chang L; Chey WD; Galligan JJ; Lacy BE; Müller-Lissner S; Quigley EM; Schuurkes J; De Maeyer JH; Stanghellini V
Aliment Pharmacol Ther; 2012 Apr; 35(7):745-67. PubMed ID: 22356640
[TBL] [Abstract][Full Text] [Related]
39. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum.
Yoshikawa T; Yoshida N; Mine Y; Hosoki K
Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060
[TBL] [Abstract][Full Text] [Related]
40. Investigations into the binding affinities of different human 5-HT4 receptor splice variants.
Irving HR; Tochon-Danguy N; Chinkwo KA; Li JG; Grabbe C; Shapiro M; Pouton CW; Coupar IM
Pharmacology; 2010; 85(4):224-33. PubMed ID: 20299822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
